Get the Stockscreener App
13.13
1.13%
-0.15
Schrodinger Inc stock is traded at $13.13, with a volume of 1.78M.
It is down -1.13% in the last 24 hours and up +14.17% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$13.28
Open:
$13.102
24h Volume:
1.78M
Relative Volume:
1.22
Market Cap:
$981.08M
Revenue:
$255.87M
Net Income/Loss:
$-103.27M
P/E Ratio:
-9.3061
EPS:
-1.4109
Net Cash Flow:
$12.46M
1W Performance:
+5.97%
1M Performance:
+14.17%
6M Performance:
-26.15%
1Y Performance:
-45.02%
1-Day Range:
$12.60
$13.21
1-Week Range:
$11.56
$13.42
52-Week Range:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
13.13 | 981.08M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
166.34 | 27.15B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
54.83 | 10.63B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.86 | 8.95B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
84.84 | 7.17B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.98 | 4.80B | 637.78M | 239.40M | 307.21M | 1.1909 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrodinger Inc stock (US80655G1067): Q1 loss and revenue miss weigh on shares - AD HOC NEWS
Analysts Have Lowered Expectations For Schrödinger, Inc. (NASDAQ:SDGR) After Its Latest Results - simplywall.st
Earnings Update: Schrödinger, Inc. (NASDAQ:SDGR) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
Schrödinger : Schrödinger Corporate Presentation - marketscreener.com
MSN Money - MSN
A Look At Schrödinger (NasdaqGS:SDGR) Valuation After Q1 Earnings And Hosted AI Software Push - Yahoo Finance
Schrödinger, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2026 Earnings Call Transcript - Insider Monkey
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
Schrödinger Reports First Quarter 2026 Financial Results - BioSpace
Schrödinger, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-05-06 - Seeking Alpha
Schrödinger Q1 2026 slides: AI platform advances amid transition By Investing.com - Investing.com South Africa
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - MSN
Schrodinger Q1 Earnings Call Highlights - Yahoo Finance
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release - MSN
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Quantisnow
Schrödinger Earnings Call: Growth Now, Profits Later - TipRanks
Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides - ChartMill
Schrödinger (SDGR) Q1 2026 Earnings Transcript - AOL.com
SDGR Financials: Income Statement, Balance Sheet & Cash Flow | Schrodinger, Inc. - Stock Titan
Earnings call transcript: Schrödinger misses EPS but beats revenue in Q1 2026 - Investing.com Nigeria
Schrödinger Q1 2026 slides: AI platform advances amid transition - Investing.com
Earnings Flash (SDGR) Schrodinger, Inc. Reports Q1 Revenue $58.6M, vs. FactSet Est of $47.6M - marketscreener.com
Schrodinger: 2Q ACV Is Expected to Range From $19M to $23M, Exclusive of Contribution ACV >SDGR - Moomoo
Q1 2026 Schrodinger Inc Earnings Call Transcript - GuruFocus
Schrödinger tees up AI drug-discovery tool as Ajax sale hits $2.3B - Stock Titan
Schrödinger (NASDAQ: SDGR) Q1 2026 revenue, loss and cash position - Stock Titan
Schrödinger, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Schrödinger (NASDAQ: SDGR) posts Q1 2026 $58.6M revenue, keeps outlook - Stock Titan
Can Schrödinger’s (SDGR) AI-Hosted Push Recast Its Investment Story Beyond Drug Discovery Hype? - simplywall.st
Here’s What the Street Thinks About Schrödinger (SDGR) - Insider Monkey
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Liquidity Mapping Around (SDGR) Price Events - Stock Traders Daily
Schrödinger to Participate in Upcoming May 2026 Investor Conferences - BioSpace
Schrödinger will webcast two healthcare conference talks in May - Stock Titan
Insider sales reported for SDGR (NASDAQ: SDGR) including 752/775/608 shares - Stock Titan
SDGR News | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
3.19M-share disclosure by Schrodinger (NASDAQ: SDGR) shows a 4.9% stake - Stock Titan
Earnings Preview: Schrodinger to Report Financial Results Post-market on May 05 - Moomoo
Vanguard Portfolio Management (SDGR) holds 3.91M shares, 6.04% stake - Stock Titan
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.66%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):